Luo Jianghong, Tang Yixin, Cao Jing, Li Wei, Zheng Liu, Lin Haomin
Department of Orthopedics, Chengdu Sixth People's Hospital, Chengdu, Sichuan, China.
Department of Medical Cosmetology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China.
J Orthop Surg Res. 2025 Feb 11;20(1):154. doi: 10.1186/s13018-025-05523-7.
Enhanced recovery after surgery (ERAS) has been widely used in several surgical fields. This meta-analysis compared the clinical outcomes of the ERAS protocol and standard care (SC) in patients who underwent lumbar interbody fusion surgery.
The PubMed, Web of Science, Cochrane Library, and Embase databases were systematically searched to identify studies reporting the effects of the ERAS protocol on clinical outcomes in patients who underwent lumbar interbody fusion surgery.
Overall, 15 studies involving 17 865 patients were included in the final analysis. With the ERAS protocol, the length of hospitalization (SMD: - 0.47, 95% CI - 0.56 to -0.38), postoperative complications (OR = 0.62; 95% CI 0.50 to 0.77), operation time (SMD = - 0.26; 95% CI - 0.44 to -0.09), postoperative pain (SMD = - 0.35; 95% CI - 0.64 to -0.07) and duration of ambulation (SMD = - 0.80; 95% CI - 1.02 to - 0.58) were significantly reduced. The rates of readmission (OR = 0.63; 95% CI 0.38 to 1.04), estimated blood loss (SMD = - 0.31; 95% CI - 0.69 to 0.06) and hospitalization costs (SMD: - 0.56, 95% CI - 1.27 to 0.14) did not significantly differ between the ERAS and SC groups.
The present meta-analysis indicated that the ERAS protocol could be safely and feasibly implemented in the perioperative management of patients receiving lumbar interbody fusion surgery. The protocol significantly reduced the length of hospitalization, incidence of postoperative complications, operation time, duration of 1st ambulation and duration of postoperative pain. However, no differences were observed in estimated blood loss, readmission rates or hospitalization costs.
术后加速康复(ERAS)已在多个外科领域广泛应用。本荟萃分析比较了接受腰椎椎间融合手术患者中ERAS方案与标准护理(SC)的临床结局。
系统检索PubMed、Web of Science、Cochrane图书馆和Embase数据库,以识别报告ERAS方案对接受腰椎椎间融合手术患者临床结局影响的研究。
最终分析共纳入15项研究,涉及17865例患者。采用ERAS方案时,住院时间(标准化均值差:-0.47,95%置信区间-0.56至-0.38)、术后并发症(比值比=0.62;95%置信区间0.50至0.77)、手术时间(标准化均值差=-0.26;95%置信区间-0.44至-0.09)、术后疼痛(标准化均值差=-0.35;95%置信区间-0.64至-0.07)和下床活动时间(标准化均值差=-0.80;95%置信区间-1.02至-0.58)均显著缩短。ERAS组与SC组在再入院率(比值比=0.63;95%置信区间0.38至1.04)、估计失血量(标准化均值差=-0.31;95%置信区间-0.69至0.06)和住院费用(标准化均值差:-0.56,95%置信区间-1.27至0.14)方面无显著差异。
本荟萃分析表明,ERAS方案可安全、可行地应用于接受腰椎椎间融合手术患者的围手术期管理。该方案显著缩短了住院时间、术后并发症发生率、手术时间、首次下床活动时间和术后疼痛持续时间。然而,在估计失血量、再入院率或住院费用方面未观察到差异。